国产bbaaaaa片,成年美女黄网站色视频免费,成年黄大片,а天堂中文最新一区二区三区,成人精品视频一区二区三区尤物

首頁(yè)> 外文期刊>Journal of clinical sleep medicine: JCSM : official publication of the American Academy of Sleep Medicine >Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015
【24h】

Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015

機(jī)譯:治療內(nèi)在晝夜節(jié)律性睡眠-覺(jué)醒障礙的臨床實(shí)踐指南:晚期睡眠-覺(jué)醒相位障礙(ASWPD),延遲性睡眠-覺(jué)醒相位障礙(DSWPD),非24小時(shí)睡眠-覺(jué)醒節(jié)奏障礙(N24SWD)和不規(guī)則的睡眠-蘇醒節(jié)律障礙(ISWRD)。 2015年更新

獲取原文
獲取原文并翻譯 | 示例

摘要

A systematic literature review and meta-analyses (where appropriate) were performed and the GRADE approach was used to update the previous American Academy of Sleep Medicine Practice Parameters on the treatment of intrinsic circadian rhythm sleep-wake disorders. Available data allowed for positive endorsement (at a second-tier degree of confidence) of strategically timed melatonin (for the treatment of DSWPD, blind adults with N24SWD, and children/adolescents with ISWRD and comorbid neurological disorders), and light therapy with or without accompanying behavioral interventions (adults with ASWPD, children/adolescents with DSWPD, and elderly with dementia). Recommendations against the use of melatonin and discrete sleep-promoting medications are provided for demented elderly patients, at a second-and first-tier degree of confidence, respectively. No recommendations were provided for remaining treatments/populations, due to either insufficient or absent data. Areas where further research is needed are discussed.
機(jī)譯:進(jìn)行了系統(tǒng)的文獻(xiàn)綜述和薈萃分析(在適當(dāng)?shù)那闆r下),并且使用GRADE方法更新了先前的美國(guó)睡眠醫(yī)學(xué)學(xué)會(huì)關(guān)于內(nèi)在的晝夜節(jié)律性睡眠-喚醒障礙的治療參數(shù)?,F(xiàn)有數(shù)據(jù)可對(duì)策略性定時(shí)褪黑素(用于治療DSWPD,患有N24SWD的失明成年人以及患有ISWRD和合并癥的神經(jīng)系統(tǒng)疾病的兒童/青少年)進(jìn)行正面認(rèn)可(在第二層置信度),以及有或沒(méi)有光療法伴隨的行為干預(yù)(成人ASWPD,兒童/青少年DSWPD和老年癡呆癥)。針對(duì)癡呆的老年患者,建議分別以二線和一線信任度反對(duì)使用褪黑激素和促進(jìn)睡眠的離散藥物。由于數(shù)據(jù)不足或不存在,未對(duì)剩余的治療/人群提供任何建議。討論了需要進(jìn)一步研究的領(lǐng)域。

著錄項(xiàng)

相似文獻(xiàn)

  • 外文文獻(xiàn)
  • 中文文獻(xiàn)
  • 專(zhuān)利
獲取原文

客服郵箱:kefu@zhangqiaokeyan.com

京公網(wǎng)安備:11010802029741號(hào) ICP備案號(hào):京ICP備15016152號(hào)-6 六維聯(lián)合信息科技 (北京) 有限公司?版權(quán)所有
  • 客服微信

  • 服務(wù)號(hào)